logo

For the Inventor, By the Inventor

Penzberg, Germany

Irene Kolm

This inventor holds 6 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Hoffmann-La Roche Inc., Roche Glycart Ag. Active years: 2007-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Irene Kolm. Retrieved from https://idiyas.com/inventor/irene-kolm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 33.3

 

Average Co-Inventor Count = 7.6

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Weilheim, DE (2007)
  • Wielheim, DE (2008)
  • Penzberg, DE (2011 - 2019)

Company Filing History:

goldMedal3 out of 5,026 
 
Hoffmann-La Roche Inc.
 patents
silverMedal3 out of 73 
 
Roche Glycart Ag
 patents

Years Active: 2007-2019

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents
1. 10196456 - Anti-HER3 antibodies and uses thereof (2019-02-05),
2. 9611331 - Anti-HER3 antibodies and uses thereof (2017-04-04),
3. 8859737 - Anti-HER3 antibodies and uses thereof (2014-10-14),
4. 8080552 - Pyrimidyl derivatives as protein kinase inhibitors (2011-12-20),
5. 7429605 - Phenylpyridine derivatives (2008-09-30),
6. 7163953 - Benzylether derivatives (2007-01-16),

Title: The Innovative Contributions of Irene Kolm

Introduction

Irene Kolm is a prominent inventor based in Penzberg, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 6 patents to her name, her work has had a substantial impact on medical research and pharmaceutical applications.

Latest Patents

Among her latest patents is the invention of anti-HER3 antibodies and their uses. This invention relates to antibodies that bind to human HER3, detailing methods for their production, pharmaceutical compositions containing these antibodies, and their various applications. This innovative work is crucial for advancing treatments in targeted therapies.

Career Highlights

Irene Kolm has worked with notable companies in the biotechnology sector, including Hoffmann-La Roche Inc. and Roche Glycart AG. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in her field.

Collaborations

Irene has collaborated with esteemed colleagues such as Birgit Bossenmaier and Thomas Friess. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to successful outcomes in their projects.

Conclusion

Irene Kolm's contributions to the field of biotechnology through her patents and collaborations highlight her role as a leading inventor. Her work continues to influence advancements in medical treatments and research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…